Isoindolinone spirooxepino indole derivative and preparation method thereof

Through the (4+3) cyclization reaction catalyzed by 9-anthracenspirocyclic phosphoric acid, the isoindolinone spirozozazhuoindole derivative was successfully synthesized, and the problem of harsh synthesis conditions in the prior art was solved, thus achieving the goal of achieving the Products with high optical activity and good fluorescence properties have been promoted to the development of new luminescent materials.

CN118908969AActive Publication Date: 2024-11-08ZHEJIANG UNIV
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202410973595.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-19
Publication Date
2024-11-08
Estimated Expiration
2044-07-19

AI Technical Summary

Technical Problem

The prior art is difficult to efficiently synthesize oxazoroindole derivatives with axial chirality, and the synthesis conditions of indole compounds are relatively harsh, which limits its wide application in the fields of medicines and materials.

Method used

Isoindolinylpropargyl alcohol compounds and 2-indole methanol compounds were cyclized under 9-anthracene spirocyclic phosphoric acid catalyzed, and isoindole was synthesized by catalytic action under mild conditions. Linone spirozozazo indole derivatives were separated by column chromatography and catalyst recovery.

Benefits of technology

The synthesis of highly optically active isoindolinone spirozozazo indole derivatives under mild conditions without metal catalysis is achieved, reducing the preparation cost and imparting good fluorescent properties to the product, with potential biological activity and Application value in luminescent materials.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118908969A_ABST
    Figure CN118908969A_ABST
Patent Text Reader

Abstract

The invention discloses an isoindolinone spirooxepino indole derivative and a preparation method thereof. The isoindolinone spirooxepino indole derivative is a levorotatory or dextrorotatory optical active body or racemate with the following structural formula, the preparation method comprises the following steps: taking isoindolinyl propargyl alcohol and a 2-indolyl methanol compound as raw materials, taking organic phosphoric acid as a catalyst, and reacting in an organic solvent to obtain the isoindolinone spirooxepino indole derivative. According to the present invention, the isoindolinone spirooxepino indole derivative is synthesized by using the catalytic (4 + 3) cyclization reaction method, the reaction condition is mild, the process is simple, the operation is convenient, and the obtained product has good fluorescent property, such that the important significance is provided for fluorescent material screening. # imgabs0 #
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of drug synthesis, and particularly relates to isoindolinone spirooxazoindole derivatives and a preparation method thereof. Background Art

[0002] Oxazolyl indole derivatives are an important class of organic compounds that are widely found in some natural products and active pharmaceutical ingredients. Figure 1 as shown in .

[0003] Therefore, the research and synthesis of axial chiral oxadiazole indole derivatives has attracted wide attention. In addition, isoindolinone and its derivatives also have important pharmacological activities. Compounds containing indole ring structural units are widely present in nature and are the most common type of alkaloids discovered so far, accounting for one-fifth of all alkaloids. Due to the unique biological properties of indole compounds, they have extremely wide applications in research fields such as organic synthesis, materials science, agricultural chemistry and pharmacology. Summary of the invention

[0004] The purpose of the present invention is to provide an isoindolinone spirooxazoindole derivative and a preparation method thereof.

[0005] The isoindolinone spirooxazoindole derivative of the present invention is a levorotatory or dextrorotatory optically active body or racemic body having the following structural formula:

[0006]

[0007] Wherein: R1 to R3 are independently selected from H, halogen, methyl, phenyl, cyclohexenyl, biphenyl, thienyl, methoxy, benzyloxy, substituted phenyl, and the substituent is selected from halogen, perfluoromethyl,

[0008] Ar is selected from phenyl, phenyl with a substituent, and the substituent is selected from halogen, methyl, methoxy, aryl, and ester.

[0009] It is preferably one of the following structural formulas:

[0010]

[0011] The method for preparing the isoindolinone spirooxazoindole derivative of the present invention comprises: using an isoindolinyl propargyl alcohol compound and a 2-indole methanol compound as raw materials, using 9-anthraspiro cyclic phosphoric acid as a catalyst, reacting in an organic solvent for 24-48 hours, and purifying to obtain the isoindolinone spirooxazoindole derivative;

[0012] The 9-anthraquinone spirocyclic phosphate is a compound having the structural formula (1), which can be a left-handed or right-handed optically active form or a racemic form:

[0013]

[0014] The structure of the isoindoline propargyl alcohol compound is shown in the following formula (2):

[0015]

[0016] The structure of the 2-indolecarbinol compound is shown in the following formula (3):

[0017]

[0018] The isoindolinyl propargyl alcohol compound is preferably one of the following compounds:

[0019]

[0020] The 2-indolecarbinol compound is preferably one of the following compounds:

[0021]

[0022] In the present invention, the organic solvent is one or more of toluene, xylene, benzene, dichloromethane, chloroform, tetrahydrofuran, 1,2-dichloroethane, fluorobenzene, chlorobenzene or 1-fluoro-1,1-dichloroethane.

[0023] In the present invention, the molar ratio of the isoindoline propargyl alcohol compound to the 2-indole methanol compound is 1.1:1, the molar ratio of the 9-anthraquinone spirophosphoric acid catalyst to the 2-indole methanol compound is 1-10:100; the reaction temperature is 15-35°C

[0024] After the reaction is completed, the final product is separated and the catalyst is recovered by column chromatography. The eluent of the column chromatography is a mixed solvent of ethyl acetate / petroleum ether. The further preferred volume ratio of ethyl acetate / petroleum ether is 1:2-3.

[0025] Reaction equation of the present invention is as follows:

[0026]

[0027] Compared with the prior art, the present invention has the following advantages:

[0028] 1) No metal catalysis is required and the reaction can be carried out under mild conditions;

[0029] 2) Isoindolinyl propargyl alcohol compounds and 2-indole methanol compounds are easy to prepare, which reduces the preparation cost of the final product;

[0030] 3) It is possible to obtain highly optically active isoindolinone spirooxazoindole derivatives;

[0031] 4) The product has good fluorescence properties and may have good biological activity.

[0032] In summary, the present invention utilizes a catalytic (4+3) cyclization reaction method to synthesize isoindolinone spirooxazoline indole derivatives, with mild reaction conditions, simple process, and convenient operation. The obtained products have potentially good fluorescent properties, which will be of great significance for the development of new luminescent materials. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] Figure 1 It is a schematic diagram of the partial structure of oxazoline indole derivatives;

[0034] Figure 2 This is a graph showing the fluorescence performance results of the compound obtained in Example 5. DETAILED DESCRIPTION

[0035] The following examples will help to understand the present invention, but are not intended to limit the present invention.

[0036] Example 1

[0037] 3-Hydroxy-3-phenylethynyl-isoindoline (0.1 mmol), (2-indolyl)-2-phenylmethanol (0.11 mmol), 9-anthraspirophosphoric acid (0.01 mmol) of the above structural formula (1), and hexafluoroisopropanol (12 mg) were added to the reaction flask, and 5 mL of 1-fluoro-1,1-dichloroethane was injected. The reaction was carried out at room temperature for 48 hours. After the reaction was completed, silica gel column chromatography was directly used, and the eluent was ethyl acetate / petroleum ether = 1:3 to obtain the corresponding optically active isoindolinone spiroxazoindole derivative with a yield of 91%. The product was characterized as follows:

[0038] Structural formula:

[0039]

[0040] Appearance: white solid;

[0041] mp293-295℃;

[0042] Optical purity: 92%ee;

[0043] HPLC analysis conditions: (Dasero chiral column, the same below) Chiralpak IE-3 (n-hexane / i-PrOH=80 / 20, 1.0 mL / min), t R (major)9.865min,t R (minor)14.954min;

[0044] Optical rotation: [α] D20 = +55° (c 1.00, CH2Cl2);

[0045] 1 H NMR (400MHz, CD2Cl2) δ7.88(s,1H),7.72–7.64(m,2H),7.61(t,J=7.5,1H),7.48(t,J=7.4,1H),7.37–7.30(m, 2H),7.29–7.14(m,12H),7.14–7.08(m,3H),6.92–6.83(m,1H),6.71(d,J=8.0,1H),6.60(s,1H),6.18(s,1H);

[0046] HRMS m / z(ESI + ): Calculated value C 37 H 27 N2O2([M+H] + )531.2067, detection value 531.2069.

[0047] Example 2

[0048] 3-Hydroxy-4-trifluorotoluene ethynyl-isoindoline (0.1 mmol), (2-indolyl)-2-phenylmethanol (0.11 mmol), 9-anthraspirophosphoric acid (0.01 mmol) of the above structural formula (1), and hexafluoroisopropanol (12 mg) were added to the reaction flask, and 5 mL of 1-fluoro-1,1-dichloroethane was injected. The reaction was carried out at room temperature for 48 hours. After the reaction was completed, silica gel column chromatography was directly used, and the eluent was ethyl acetate / petroleum ether = 1:3 to obtain the corresponding optically active isoindolinone spiroxazoindole derivative with a yield of 84%. The product was characterized as follows:

[0049] Structural formula:

[0050]

[0051] Appearance: white solid;

[0052] mp321-323℃;

[0053] Optical purity: 87%ee;

[0054] HPLC analysis conditions: Chiralpak IE-3 (n-hexane / i-PrOH=80 / 20, 1.0 mL / min), t R (minor)6.809min,t R (major)11.521min;

[0055] Optical rotation: [α]D 20 = +29° (c 1.0, CH2Cl2);

[0056] 1 H NMR(400MHz,CD2Cl2)δ8.11(s,1H),7.80–7.68(m,3H),7.63–7.51(m,3H),7.45– 7.19(m,14H),7.00(t,J=7.6,1H),6.79(d,J=8.1,1H),6.72(s,1H),6.35(s,1H);

[0057] HRMS m / z(ESI + ): Calculated value C 38 H 26 F3N2O2([M+H] + )599.1941, detection value 599.1945.

[0058] Example 3

[0059] 3-Hydroxy-4-iodophenylethynyl-isoindoline (0.1 mmol), (2-indolyl)-2-phenylmethanol (0.11 mmol), 9-anthraspirophosphoric acid (0.01 mmol) of the above structural formula (1), and hexafluoroisopropanol (12 mg) were added to the reaction flask, and 5 mL of 1-fluoro-1,1-dichloroethane was injected. The reaction was carried out at room temperature for 48 hours. After the reaction was completed, silica gel column chromatography was directly used, and the eluent was ethyl acetate / petroleum ether = 1:3 to obtain the corresponding optically active isoindolinone spiroxazoindole derivative with a yield of 87%. The product was characterized as follows:

[0060] Structural formula:

[0061]

[0062] Appearance: white solid;

[0063] mp314-316℃;

[0064] Optical purity: 90%ee;

[0065] HPLC analysis conditions: Chiralpak IE-3 (n-hexane / i-PrOH=85 / 15, 1.0 mL / min), t R (major)11.170min,t R (minor)20.114min;

[0066] Optical rotation: [α] D 20= +68° (c 1.0, CH2Cl2);

[0067] 1 H NMR(400MHz,CD2Cl2)δ7.99(s,1H),7.81–7.67(m,3H),7.64–7.54(m,3H),7.51– 7.12(m,12H),7.04–6.92(m,3H),6.84(d,J=7.9,1H),6.68(s,1H),6.27(s,1H);

[0068] HRMS m / z(ESI + ): Calculated value C 37 H 26 IN2O2([M+H] + )657.1033, detected value 657.1036.

[0069] Example 4

[0070] 3-Hydroxy-3-thienylethynyl-isoindoline (0.1 mmol), (2-indolyl)-2-phenylmethanol (0.11 mmol), 9-anthraspirophosphoric acid (0.01 mmol) of the above structural formula (1), and hexafluoroisopropanol (12 mg) were added to the reaction flask, and 5 mL of 1-fluoro-1,1-dichloroethane was injected. The reaction was carried out at room temperature for 48 hours. After the reaction was completed, silica gel column chromatography was directly used, and the eluent was ethyl acetate / petroleum ether = 1:3 to obtain the corresponding optically active isoindolinone spiroxazoindole derivative with a yield of 83%. The product was characterized as follows:

[0071] Structural formula:

[0072]

[0073] Appearance: white solid;

[0074] mp270-272℃;

[0075] Optical purity: 95%ee;

[0076] HPLC analysis conditions: Chiralpak IE-3 (n-hexane / i-PrOH=80 / 20, 1.0 mL / min), t R (minor)8.738min,t R (major)13.767min;

[0077] Optical rotation: [α] D 20 = +65° (c 1.0, CH2Cl2);

[0078] 1 H NMR (400MHz, CD2Cl2) δ7.87(s,1H),7.71–7.57(m,3H),7.47(t,J=7.2,1H),7.37–7.11(m,1 3H),7.05(d,J=8.0,1H),6.97(t,J=7.5,1H),6.91–6.85(m,2H),6.48(s,1H),6.21(s,1H);

[0079] HRMS m / z(ESI + ): Calculated value C 35 H 25 N2O2S([M+H] + )537.1631, detected value 537.1634.

[0080] Example 5

[0081] 3-Hydroxy-1-cyclohexeneethynyl-isoindoline (0.1 mmol), (2-indolyl)-2-phenylmethanol (0.11 mmol), 9-anthraspirophosphoric acid (0.01 mmol) of the above structural formula (1), and hexafluoroisopropanol (12 mg) were added to the reaction flask, and 5 mL of 1-fluoro-1,1-dichloroethane was injected. The reaction was carried out at room temperature for 48 hours. After the reaction was completed, silica gel column chromatography was directly used, and the eluent was ethyl acetate / petroleum ether = 1:3 to obtain the corresponding optically active isoindolinone spiroxazoindole derivative with a yield of 76%. The product was characterized as follows:

[0082] Structural formula:

[0083]

[0084] Appearance: Yellow solid;

[0085] mp291-293℃;

[0086] Optical purity: 83%ee;

[0087] HPLC analysis conditions: Chiralpak IE-3 (n-hexane / i-PrOH=90 / 10, 1.0 mL / min), t R (minor)15.418min,t R (major)17.001min;

[0088] Optical rotation: [α] D 20 = +94° (c 1.0, CH2Cl2);

[0089] 1H NMR (400MHz, CD2Cl2) δ7.84(s,1H),7.74(d,J=7.8,1H),7.71(d,J=7.5,1H),7.60( t,J=7.6,1H),7.51–7.37(m,7H),7.37–7.31(m,3H),7.24(t,J=7.5,2H),7.20–7.1 3(m,2H),6.99(t,J=7.6,1H),6.86(s,1H),6.39(s,1H),4.54(s,1H),2.72–2.52(m ,1H),2.24–2.14(m,1H),2.07–1.97(m,1H),1.89–1.79(m,3H),1.31–1.23(m,2H);

[0090] HRMS m / z(ESI + ): Calculated value C 37 H 31 N2O2([M+H] + )535.2380, detection value 535.2382.

[0091] Example 6

[0092] 3-Hydroxy-5,6-dimethyl-3-phenylethynyl-isoindoline (0.1 mmol), (2-indolyl)-2-phenylmethanol (0.11 mmol), 9-anthraspirophosphoric acid (0.01 mmol) of the above structural formula (1), and hexafluoroisopropanol (12 mg) were added to the reaction flask, and 5 mL of 1-fluoro-1,1-dichloroethane was injected. The reaction was carried out at room temperature for 48 hours. After the reaction was completed, silica gel column chromatography was directly used, and the eluent was ethyl acetate / petroleum ether = 1:3 to obtain the corresponding optically active isoindolinone spiroxazoindole derivative with a yield of 83%. The product was characterized as follows:

[0093] Structural formula:

[0094]

[0095] Appearance: white solid;

[0096] mp327-329℃;

[0097] Optical purity: 94%ee;

[0098] HPLC analysis conditions: Chiralpak IE-3 (n-hexane / i-PrOH=80 / 20, 1.0 mL / min), t R (minor)9.129min,t R (major)14.977min;

[0099] Optical rotation: [α] D 20 = -38° (c 1.0, CH2Cl2);

[0100] 1 H NMR (400MHz, CD2Cl2) δ11.42(s,1H),8.25(d,J=8.5Hz,1H),7.70(d,J=7.8Hz,1H),7.60(ddd,J=8.3,6.9,1.1Hz,1H),7.46(ddd,J=8.1, 7.0,1.0Hz,1H),7.30–6.98(m,8H),6.78(dd,J=7.8,0.6Hz,1H),6.19(dd,J=8.2,0.6Hz,1H),4.25–4.04(m,2H),0.87(t,J=7.1Hz,3H);

[0101] HRMS m / z(ESI + ): Calculated value C 39 H 31 N2O2([M+H] + )559.2380, detection value 559.2387.

[0102] Example 7

[0103] 3-Hydroxy-5,6-dibromo-3-phenylethynyl-isoindoline (0.1 mmol), (2-indolyl)-2-phenylmethanol (0.11 mmol), 9-anthraspirophosphoric acid (0.01 mmol) of the above structural formula (1), and hexafluoroisopropanol (12 mg) were added to the reaction flask, and 5 mL of 1-fluoro-1,1-dichloroethane was injected. The reaction was carried out at room temperature for 48 hours. After the reaction was completed, silica gel column chromatography was directly used, and the eluent was ethyl acetate / petroleum ether = 1:3 to obtain the corresponding optically active isoindolinone spiroxazoindole derivative with a yield of 88%. The product was characterized as follows:

[0104] Structural formula:

[0105]

[0106] Appearance: white solid;

[0107] mp332-334℃;

[0108] Optical purity: 95%ee;

[0109] HPLC analysis conditions: Chiralpak IE-3 (n-hexane / i-PrOH=85 / 15, 1.0 mL / min), t R(minor)7.712min,t R (major)11.678min;

[0110] Optical rotation: [α] D 20 = -10° (c 1.0, CH2Cl2);

[0111] 1 H NMR(400MHz,CD2Cl2)δ8.01(s,1H),7.86(s,1H),7.75–7.61(m,2H),7.46–7.1 6(m,16H),6.98(t,J=7.6,1H),6.81(d,J=8.1,1H),6.70(s,1H),6.22(s,1H);

[0112] HRMS m / z(ESI + ): Calculated value C 37 H 24 Br2N2NaO2([M+Na] + )711.0076, detected value 711.0066.

[0113] Example 8 Fluorescence measurement:

[0114] The skeleton of the compound isoindolinone spirooxazoindole can be used for new functional materials and is a structural unit with high application value, including organic light-emitting diodes, electroluminescent materials and organic transistors.

[0115] The present invention studies the fluorescence spectral properties of some compounds obtained in the examples. Figure 2 The fluorescence performance of the compound obtained in Example 5 is shown in Figure 1. First, the fluorescence spectrum of the compound in Example 5 was measured in a diluted dichloromethane solution. The wavelength of the compound in Example 5 tested in liquid fluorescence is between 400 and 650 nm, wherein the maximum wavelength in the DCM solution is about 490 nm ( Figure 2 In addition, we also tested the fluorescence quantum yield of the selected compounds to be 0.15, and the compounds were photographed under UV light (λex=365nm), showing a light green color. In addition, all tested compounds also showed solid-state fluorescence emission ( Figure 2 b), the compound of Example 5 exhibits extremely high fluorescence intensity in the solid state, in the wavelength range of 425 to 650 nm, with a maximum wavelength of about 505 nm. In addition, the solid compound is photographed under a UV lamp (λex = 365 nm), showing a bright yellow color. The compounds obtained in other examples also have similar performances. The isoindolinone spirooxazoline indole derivatives obtained in the present invention have good fluorescence properties, which is of great significance for the development of new luminescent materials.

Claims

1. An isoindolinone spirooxazoindole derivative, characterized in that: It is a left-handed or right-handed optically active body or racemate having the following structural formula; Wherein: R1 to R3 are independently selected from H, halogen, methyl, phenyl, cyclohexenyl, biphenyl, thienyl, methoxy, benzyloxy, substituted phenyl, and the substituent is selected from halogen and perfluoromethyl; Ar is selected from phenyl, phenyl with a substituent, and the substituent is selected from halogen, methyl, methoxy, aryl, and ester.

2. The isoindolinone spirooxazoindole derivative according to claim 1, characterized in that: One of the following structural formulas:

3. The method for preparing the isoindolinone spirooxazoindole derivative according to claim 1, characterized in that: The method comprises using isoindolinyl propargyl alcohol compounds and 2-indole methanol compounds as raw materials, using 9-anthraspiro cyclic phosphoric acid as a catalyst, reacting in an organic solvent at room temperature for 24 to 48 hours, and purifying to obtain isoindolinone spirooxazoindole derivatives; The 9-anthraquinone spirocyclic phosphate is a compound having the structural formula (1), which can be a left-handed or right-handed optically active form or a racemic form: The structure of the isoindoline propargyl alcohol compound is shown in the following formula (2): The structure of the 2-indolecarbinol compound is shown in the following formula (3):

4. The method for preparing the isoindolinone spirooxazoindole derivative according to claim 3, characterized in that: The isoindolinyl propargyl alcohol compound is preferably one of the following compounds:

5. The method for preparing the isoindolinone spirooxazoindole derivative according to claim 3, characterized in that: The 2-indolecarbinol compound is preferably one of the following compounds:

6. The method for preparing the isoindolinone spirooxazoindole derivative according to claim 3, characterized in that: The organic solvent is one or more of toluene, xylene, benzene, dichloromethane, chloroform, tetrahydrofuran, 1,2-dichloroethane, fluorobenzene, chlorobenzene, hexafluoroisopropanol or 1-fluoro-1,1-dichloroethane.

7. The method for preparing the isoindolinone spiroxazoindole derivative according to claim 3, characterized in that: The molar ratio of the isoindoline propargyl alcohol compound to the 2-indole methanol compound is 1.1:1, the molar ratio of the 9-anthraquinone spirocyclic phosphoric acid catalyst to the 2-indole methanol compound is 1-10:100; and the reaction temperature is 15-35°C.

Citation Information

Patent Citations

  • Method for synthesizing optical activity spiro-oxindole tetrahydroquinoline derivative

    CN104844601A

  • Preparation method of optically active 3-(1,1-difluoro-2-oxo-2-arylethyl)isoindoline-1-one derivative

    CN112010796A